White Guide and Orange Guide Formatting Project - Pfizer

Orange Guide – Chapter 8: Privacy: Protecting Personal Information
Chapter 8: PRIVACY: PROTECTING PERSONAL
INFORMATION
CONTENTS
Privacy: Protecting Personal Information
Privacy ............................................................................................................................................................................. 3
Patients’ Privacy and Personal Information .................................................................................................................. 3
Key Points to Ensure Compliance ........................................................................................................................ 4
Laws Protecting Personal Data ..................................................................................................................................... 5
Business Associate Agreements and Confidentiality Agreements ............................................................................. 5
State and Other Privacy Laws ............................................................................................................................... 7
Steps to Protect Patient Privacy .................................................................................................................................... 7
Avoid Intentional and Inadvertent Disclosure of Sensitive Personal Information ............................................. 7
Seek Only De-Identified Data .............................................................................................................................. 8
Obtain Patient Consent (via Signed Authorization) Where Appropriate .......................................................... 8
Mentorships and Preceptorships ......................................................................................................................... 9
Handling Patients' Personal Data ................................................................................................................................ 10
Pfizer-Sponsored Third Party Communications to Patients............................................................................. 10
Consumer Health Fairs and Screenings ............................................................................................................. 11
Securing Consent and Personal Information from Consumers ................................................................................. 12
Handling HCP Personal Data ....................................................................................................................................... 13
Restricting Access to Personal Information to a “Need to Know” Basis .......................................................... 13
Proper Use of HCP Prescriber Data .................................................................................................................... 14
134
Rev. 09/12
Page 1 of 18